Binding of apolipoprotein E inhibits the oligomer growth of amyloid beta peptide in solution as determined by fluorescence cross correlation spectroscopy

Ly S, Altman R, Petrlova J, Lin Y, Hilt S, Huser T, Laurence T, Voss J (2013)
Journal of Biological Chemistry 288(17): 11628-11635.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
DOI
Autor*in
Ly, Sonny; Altman, Robin; Petrlova, Jitka; Lin, Y.; Hilt, S.; Huser, ThomasUniBi ; Laurence, Ted; Voss, John
Einrichtung
Fakultät für Physik
Erscheinungsjahr
2013
Zeitschriftentitel
Journal of Biological Chemistry
Band
288
Ausgabe
17
Seite(n)
11628-11635
ISSN
0021-9258
eISSN
1083-351X
Page URI
https://pub.uni-bielefeld.de/record/2578275

Zitieren

Ly S, Altman R, Petrlova J, et al. Binding of apolipoprotein E inhibits the oligomer growth of amyloid beta peptide in solution as determined by fluorescence cross correlation spectroscopy. Journal of Biological Chemistry. 2013;288(17):11628-11635.
Ly, S., Altman, R., Petrlova, J., Lin, Y., Hilt, S., Huser, T., Laurence, T., et al. (2013). Binding of apolipoprotein E inhibits the oligomer growth of amyloid beta peptide in solution as determined by fluorescence cross correlation spectroscopy. Journal of Biological Chemistry, 288(17), 11628-11635. doi:10.1074/jbc.m112.411900
Ly, Sonny, Altman, Robin, Petrlova, Jitka, Lin, Y., Hilt, S., Huser, Thomas, Laurence, Ted, and Voss, John. 2013. “Binding of apolipoprotein E inhibits the oligomer growth of amyloid beta peptide in solution as determined by fluorescence cross correlation spectroscopy”. Journal of Biological Chemistry 288 (17): 11628-11635.
Ly, S., Altman, R., Petrlova, J., Lin, Y., Hilt, S., Huser, T., Laurence, T., and Voss, J. (2013). Binding of apolipoprotein E inhibits the oligomer growth of amyloid beta peptide in solution as determined by fluorescence cross correlation spectroscopy. Journal of Biological Chemistry 288, 11628-11635.
Ly, S., et al., 2013. Binding of apolipoprotein E inhibits the oligomer growth of amyloid beta peptide in solution as determined by fluorescence cross correlation spectroscopy. Journal of Biological Chemistry, 288(17), p 11628-11635.
S. Ly, et al., “Binding of apolipoprotein E inhibits the oligomer growth of amyloid beta peptide in solution as determined by fluorescence cross correlation spectroscopy”, Journal of Biological Chemistry, vol. 288, 2013, pp. 11628-11635.
Ly, S., Altman, R., Petrlova, J., Lin, Y., Hilt, S., Huser, T., Laurence, T., Voss, J.: Binding of apolipoprotein E inhibits the oligomer growth of amyloid beta peptide in solution as determined by fluorescence cross correlation spectroscopy. Journal of Biological Chemistry. 288, 11628-11635 (2013).
Ly, Sonny, Altman, Robin, Petrlova, Jitka, Lin, Y., Hilt, S., Huser, Thomas, Laurence, Ted, and Voss, John. “Binding of apolipoprotein E inhibits the oligomer growth of amyloid beta peptide in solution as determined by fluorescence cross correlation spectroscopy”. Journal of Biological Chemistry 288.17 (2013): 11628-11635.

15 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Amyloid-β and tau complexity - towards improved biomarkers and targeted therapies.
Polanco JC, Li C, Bodea LG, Martinez-Marmol R, Meunier FA, Götz J., Nat Rev Neurol 14(1), 2018
PMID: 29242522
The effects of fluorescent labels on Aβ42 aggregation detected by fluorescence correlation spectroscopy.
Zheng Y, Xu L, Yang J, Peng X, Wang H, Yu N, Hua Y, Zhao J, He J, Hong T., Biopolymers 109(11), 2018
PMID: 30311215
Clusterin Binds to Aβ1-42 Oligomers with High Affinity and Interferes with Peptide Aggregation by Inhibiting Primary and Secondary Nucleation.
Beeg M, Stravalaci M, Romeo M, Carrá AD, Cagnotto A, Rossi A, Diomede L, Salmona M, Gobbi M., J Biol Chem 291(13), 2016
PMID: 26884339
Study of Exosomes Shed New Light on Physiology of Amyloidogenesis.
van Niel G., Cell Mol Neurobiol 36(3), 2016
PMID: 26983829
Kinesin-1 inhibits the aggregation of amyloid-β peptide as detected by fluorescence cross-correlation spectroscopy.
Zheng Y, Tian S, Peng X, Yang J, Fu Y, Jiao Y, Zhao J, He J, Hong T., FEBS Lett 590(7), 2016
PMID: 26991731
ApoE: the role of conserved residues in defining function.
Frieden C., Protein Sci 24(1), 2015
PMID: 25377861
How our bodies fight amyloidosis: effects of physiological factors on pathogenic aggregation of amyloidogenic proteins.
Huang L, Liu X, Cheng B, Huang K., Arch Biochem Biophys 568(), 2015
PMID: 25615529
Neuronal response in Alzheimer's and Parkinson's disease: the effect of toxic proteins on intracellular pathways.
Majd S, Power JH, Grantham HJ., BMC Neurosci 16(), 2015
PMID: 26499115
Chronic Microdose Lithium Treatment Prevented Memory Loss and Neurohistopathological Changes in a Transgenic Mouse Model of Alzheimer's Disease.
Nunes MA, Schöwe NM, Monteiro-Silva KC, Baraldi-Tornisielo T, Souza SI, Balthazar J, Albuquerque MS, Caetano AL, Viel TA, Buck HS., PLoS One 10(11), 2015
PMID: 26605788
Soluble apoE/Aβ complex: mechanism and therapeutic target for APOE4-induced AD risk.
Tai LM, Mehra S, Shete V, Estus S, Rebeck GW, Bu G, LaDu MJ., Mol Neurodegener 9(), 2014
PMID: 24386905
Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
Martínez-Morillo E, Hansson O, Atagi Y, Bu G, Minthon L, Diamandis EP, Nielsen HM., Acta Neuropathol 127(5), 2014
PMID: 24633805
Amyloid-β pathology and APOE genotype modulate retinoid X receptor agonist activity in vivo.
Tai LM, Koster KP, Luo J, Lee SH, Wang YT, Collins NC, Ben Aissa M, Thatcher GR, LaDu MJ., J Biol Chem 289(44), 2014
PMID: 25217640
The binding of apolipoprotein E to oligomers and fibrils of amyloid-β alters the kinetics of amyloid aggregation.
Garai K, Verghese PB, Baban B, Holtzman DM, Frieden C., Biochemistry 53(40), 2014
PMID: 25207746
Pharmacological inhibition of dynamin II reduces constitutive protein secretion from primary human macrophages.
Kockx M, Karunakaran D, Traini M, Xue J, Huang KY, Nawara D, Gaus K, Jessup W, Robinson PJ, Kritharides L., PLoS One 9(10), 2014
PMID: 25347775
On the subject of rigor in the study of amyloid β-protein assembly.
Teplow DB., Alzheimers Res Ther 5(4), 2013
PMID: 23981712

52 References

Daten bereitgestellt von Europe PubMed Central.

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.
Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA., Science 261(5123), 1993
PMID: 8346443
Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage.
Pericak-Vance MA, Bebout JL, Gaskell PC Jr, Yamaoka LH, Hung WY, Alberts MJ, Walker AP, Bartlett RJ, Haynes CA, Welsh KA., Am. J. Hum. Genet. 48(6), 1991
PMID: 2035524
Detrimental effects of apolipoprotein E4: potential therapeutic targets in Alzheimer's disease.
Mahley RW, Huang Y, Weisgraber KH., Curr Alzheimer Res 4(5), 2007
PMID: 18220516
Apolipoprotein E in Alzheimer's disease and other neurological disorders.
Verghese PB, Castellano JM, Holtzman DM., Lancet Neurol 10(3), 2011
PMID: 21349439
Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease.
Namba Y, Tomonaga M, Kawasaki H, Otomo E, Ikeda K., Brain Res. 541(1), 1991
PMID: 2029618
Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.
Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD., Proc. Natl. Acad. Sci. U.S.A. 90(5), 1993
PMID: 8446617
Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease.
Strittmatter WJ, Weisgraber KH, Huang DY, Dong LM, Salvesen GS, Pericak-Vance M, Schmechel D, Saunders AM, Goldgaber D, Roses AD., Proc. Natl. Acad. Sci. U.S.A. 90(17), 1993
PMID: 8367470
Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid.
Wisniewski T, Frangione B., Neurosci. Lett. 135(2), 1992
PMID: 1625800
Role of apoe/Abeta interactions in the pathogenesis of Alzheimer's disease and cerebral amyloid angiopathy.
Holtzman DM., J. Mol. Neurosci. 17(2), 2001
PMID: 11816788
Neurovascular pathways and Alzheimer amyloid beta-peptide.
Zlokovic BV, Deane R, Sallstrom J, Chow N, Miano JM., Brain Pathol. 15(1), 2005
PMID: 15779240
ApoE and Abeta1-42 interactions: effects of isoform and conformation on structure and function.
Manelli AM, Stine WB, Van Eldik LJ, LaDu MJ., J. Mol. Neurosci. 23(3), 2004
PMID: 15181252
APOE genotype results in differential effects on the peripheral clearance of amyloid-beta42 in APOE knock-in and knock-out mice.
Sharman MJ, Morici M, Hone E, Berger T, Taddei K, Martins IJ, Lim WL, Singh S, Wenk MR, Ghiso J, Buxbaum JD, Gandy S, Martins RN., J. Alzheimers Dis. 21(2), 2010
PMID: 20555142
Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease.
Holtzman DM, Bales KR, Wu S, Bhat P, Parsadanian M, Fagan AM, Chang LK, Sun Y, Paul SM., J. Clin. Invest. 103(6), 1999
PMID: 10079115
In vivo human apolipoprotein E isoform fractional turnover rates in the CNS.
Wildsmith KR, Basak JM, Patterson BW, Pyatkivskyy Y, Kim J, Yarasheski KE, Wang JX, Mawuenyega KG, Jiang H, Parsadanian M, Yoon H, Kasten T, Sigurdson WC, Xiong C, Goate A, Holtzman DM, Bateman RJ., PLoS ONE 7(6), 2012
PMID: 22675504
Measurement of apolipoprotein E and amyloid β clearance rates in the mouse brain using bolus stable isotope labeling.
Basak JM, Kim J, Pyatkivskyy Y, Wildsmith KR, Jiang H, Parsadanian M, Patterson BW, Bateman RJ, Holtzman DM., Mol Neurodegener 7(), 2012
PMID: 22512932
Fluorescence correlation spectroscopy applied to rotational diffusion of macromolecules.
Ehrenberg M, Rigler R., Q. Rev. Biophys. 9(1), 1976
PMID: 1273258
Statistical accuracy in fluorescence correlation spectroscopy
Koppel D.., 1974
Thermodynamic fluctuations in a reacting system —- measurement by fluorescence correlation spectroscopy
Magde D., Elson E., Webb W.., 1972
Dual-color fluorescence cross-correlation spectroscopy for multicomponent diffusional analysis in solution.
Schwille P, Meyer-Almes FJ, Rigler R., Biophys. J. 72(4), 1997
PMID: 9083691
Fluorescence cross-correlation spectroscopy in living cells.
Bacia K, Kim SA, Schwille P., Nat. Methods 3(2), 2006
PMID: 16432516
Real-time enzyme kinetics monitored by dual-color fluorescence cross-correlation spectroscopy.
Kettling U, Koltermann A, Schwille P, Eigen M., Proc. Natl. Acad. Sci. U.S.A. 95(4), 1998
PMID: 9465029
A protease assay for two-photon crosscorrelation and FRET analysis based solely on fluorescent proteins.
Kohl T, Heinze KG, Kuhlemann R, Koltermann A, Schwille P., Proc. Natl. Acad. Sci. U.S.A. 99(19), 2002
PMID: 12209012
Intracellular calmodulin availability accessed with two-photon cross-correlation.
Kim SA, Heinze KG, Waxham MN, Schwille P., Proc. Natl. Acad. Sci. U.S.A. 101(1), 2003
PMID: 14695888
Fluorescence-aided molecule sorting: analysis of structure and interactions by alternating-laser excitation of single molecules.
Kapanidis AN, Lee NK, Laurence TA, Doose S, Margeat E, Weiss S., Proc. Natl. Acad. Sci. U.S.A. 101(24), 2004
PMID: 15175430
Cross talk free fluorescence cross correlation spectroscopy in live cells.
Thews E, Gerken M, Eckert R, Zapfel J, Tietz C, Wrachtrup J., Biophys. J. 89(3), 2005
PMID: 15951373
Pulsed interleaved excitation.
Muller BK, Zaychikov E, Brauchle C, Lamb DC., Biophys. J. 89(5), 2005
PMID: 16113120
Motion of a DNA sliding clamp observed by single molecule fluorescence spectroscopy.
Laurence TA, Kwon Y, Johnson A, Hollars CW, O'Donnell M, Camarero JA, Barsky D., J. Biol. Chem. 283(34), 2008
PMID: 18556658
Fluorescence cross-correlation spectroscopy as a universal method for protein detection with low false positives.
Miller AE, Hollars CW, Lane SM, Laurence TA., Anal. Chem. 81(14), 2009
PMID: 19522509
A differential association of Apolipoprotein E isoforms with the amyloid-β oligomer in solution.
Petrlova J, Hong HS, Bricarello DA, Harishchandra G, Lorigan GA, Jin LW, Voss JC., Proteins 79(2), 2011
PMID: 21069870
VLDL lipolysis products increase VLDL fluidity and convert apolipoprotein E4 into a more expanded conformation.
Tetali SD, Budamagunta MS, Simion C, den Hartigh LJ, Kalai T, Hideg K, Hatters DM, Weisgraber KH, Voss JC, Rutledge JC., J. Lipid Res. 51(6), 2009
PMID: 19965582
C-terminal interactions of apolipoprotein E4 respond to the postprandial state.
Tetali SD, Budamagunta MS, Voss JC, Rutledge JC., J. Lipid Res. 47(7), 2006
PMID: 16632798
Candidate anti-A beta fluorene compounds selected from analogs of amyloid imaging agents.
Hong HS, Maezawa I, Budamagunta M, Rana S, Shi A, Vassar R, Liu R, Lam KS, Cheng RH, Hua DH, Voss JC, Jin LW., Neurobiol. Aging 31(10), 2008
PMID: 19022536
The influence of spin-labeled fluorene compounds on the assembly and toxicity of the aβ peptide.
Petrlova J, Kalai T, Maezawa I, Altman R, Harishchandra G, Hong HS, Bricarello DA, Parikh AN, Lorigan GA, Jin LW, Hideg K, Voss JC., PLoS ONE 7(4), 2012
PMID: 22558151
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis.
Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, Glabe CG., Science 300(5618), 2003
PMID: 12702875
Postprandial apoE isoform and conformational changes associated with VLDL lipolysis products modulate monocyte inflammation.
den Hartigh LJ, Altman R, Hutchinson R, Petrlova J, Budamagunta MS, Tetali SD, Lagerstedt JO, Voss JC, Rutledge JC., PLoS ONE 7(11), 2012
PMID: 23209766
Apolipoprotein E structural requirements for the formation of SDS-stable complexes with beta-amyloid-(1-40): the role of salt bridges.
Bentley NM, Ladu MJ, Rajan C, Getz GS, Reardon CA., Biochem. J. 366(Pt 1), 2002
PMID: 12015813
Fibrillar oligomers nucleate the oligomerization of monomeric amyloid beta but do not seed fibril formation.
Wu JW, Breydo L, Isas JM, Lee J, Kuznetsov YG, Langen R, Glabe C., J. Biol. Chem. 285(9), 2009
PMID: 20018889
Monte Carlo study of the formation and conformational properties of dimers of Aβ42 variants.
Mitternacht S, Staneva I, Hard T, Irback A., J. Mol. Biol. 410(2), 2011
PMID: 21616081
Isoform-specific binding of apolipoprotein E to beta-amyloid.
LaDu MJ, Falduto MT, Manelli AM, Reardon CA, Getz GS, Frail DE., J. Biol. Chem. 269(38), 1994
PMID: 8089103
Zinc-induced Alzheimer's Abeta1-40 aggregation is mediated by conformational factors.
Huang X, Atwood CS, Moir RD, Hartshorn MA, Vonsattel JP, Tanzi RE, Bush AI., J. Biol. Chem. 272(42), 1997
PMID: 9334223
Apolipoprotein e sets the stage: response to injury triggers neuropathology.
Mahley RW, Huang Y., Neuron 76(5), 2012
PMID: 23217737
Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E.
Mahley RW, Ji ZS., J. Lipid Res. 40(1), 1999
PMID: 9869645
Stoichiometry of reconstituted high-density lipoproteins in the hydrated state determined by photon antibunching.
Ly S, Petrlova J, Huser T, Fore S, Gao T, Voss J, Laurence TA., Biophys. J. 101(4), 2011
PMID: 21843489
Characterizing diffusion dynamics of a membrane protein associated with nanolipoproteins using fluorescence correlation spectroscopy.
Gao T, Blanchette CD, He W, Bourguet F, Ly S, Katzen F, Kudlicki WA, Henderson PT, Laurence TA, Huser T, Coleman MA., Protein Sci. 20(2), 2011
PMID: 21280134
The role of apolipoprotein E in Alzheimer's disease.
Kim J, Basak JM, Holtzman DM., Neuron 63(3), 2009
PMID: 19679070
C-terminal-truncated apolipoprotein (apo) E4 inefficiently clears amyloid-beta (Abeta) and acts in concert with Abeta to elicit neuronal and behavioral deficits in mice.
Bien-Ly N, Andrews-Zwilling Y, Xu Q, Bernardo A, Wang C, Huang Y., Proc. Natl. Acad. Sci. U.S.A. 108(10), 2011
PMID: 21368138
Human apoE isoforms differentially regulate brain amyloid-β peptide clearance
Castellano J., Kim J., Stewart F., Jiang H., DeMattos R., Patterson B., Fagan A., Morris J., Mawuenyega K., Cruchaga C., Goate A., Bales K., Paul S., Bateman R., Holtzman D.., 2011
Haploinsufficiency of human APOE reduces amyloid deposition in a mouse model of amyloid-β amyloidosis.
Kim J, Jiang H, Park S, Eltorai AE, Stewart FR, Yoon H, Basak JM, Finn MB, Holtzman DM., J. Neurosci. 31(49), 2011
PMID: 22159114
ApoE genotype accounts for the vast majority of AD risk and AD pathology.
Raber J, Huang Y, Ashford JW., Neurobiol. Aging 25(5), 2004
PMID: 15172743
Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database.
Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE., Nat. Genet. 39(1), 2007
PMID: 17192785
Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.
Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, van Duijn CM., JAMA 278(16), 1997
PMID: 9343467
Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy.
Bu G., Nat. Rev. Neurosci. 10(5), 2009
PMID: 19339974
Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®
Quellen

PMID: 23430745
PubMed | Europe PMC

Suchen in

Google Scholar